Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2020 Aug;2(8):e457-ee458.
doi: 10.1016/S2665-9913(20)30167-3. Epub 2020 Jun 4.

Canakinumab in a subgroup of patients with COVID-19

Affiliations

Canakinumab in a subgroup of patients with COVID-19

Claudio Ucciferri et al. Lancet Rheumatol. 2020 Aug.
No abstract available

PubMed Disclaimer

References

    1. Weiss P, Murdoch DR. Clinical course and mortality risk of severe COVID-19. Lancet. 2020;395:1014–1015. - PMC - PubMed
    1. Siu K-L, Yuen K-S, Castano-Rodriguez C. Severe acute respiratory syndrome coronavirus ORF3a protein activates the NLRP3 inflammasome by promoting TRAF3-dependent ubiquitination of ASC. FASEB J. 2019;33:8865–8877. - PMC - PubMed
    1. Cavalli G, De Luca G, Campochiaro C. Interleukin-1 blockade with high-dose anakinra in patients with COVID-19, acute respiratory distress syndrome, and hyperinflammation: a retrospective cohort study. Lancet Rheumatol. 2020;2:e325–e331. - PMC - PubMed
    1. Geleris J, Sun Y, Platt J. Observational study of hydroxychloroquine in hospitalized patients with Covid-19. N Engl J Med. 2020 doi: 10.1056/NEJMoa2012410. published online May 7. - DOI - PMC - PubMed
    1. Abbate A, Toldo S, Marchetti C, Kron J, Van Tassell BW, Dinarello CA. Interleukin-1 and the inflammasome as therapeutic targets in cardiovascular disease. Circ Res. 2020;126:1260–1280. - PMC - PubMed

LinkOut - more resources